Press Release QAD | Redzone Champions of Manufacturing Thailand Kicks Off in Bangkok, Igniting the Next Era of AI-Powered Manufacturing 15 May 2026
Press Release Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― Published in The Lancet 15 May 2026
Press Release Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― Published in The Lancet 15 May 2026
Press Release Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― Published in The Lancet 15 May 2026
Press Release ACI Worldwide and Security Bank Philippines Set New Benchmark for Enterprise-wide Payments Modernization 15 May 2026
Press Release CORRECTING and REPLACING JBT Marel Corporation Declares Quarterly Dividend and Announces Share Repurchase Program 14 May 2026
